New oxabispidine compounds useful in the treatment of cardiac arrhythmias
申请人:Bjore Annika
公开号:US20060166979A1
公开(公告)日:2006-07-27
There is provided compounds of formula I,
wherein R
1
, R
2
, R
3
, R
4
, R
41
to R
46
, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
Oxabispidine compounds useful in the treatment of cardiac arrhythmias
申请人:Bjore Annika
公开号:US20070117799A1
公开(公告)日:2007-05-24
There is provided compounds of formula I,
wherein R
1
, R
2
, R
3
, R
4
, R
41
to R
46
, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
New oxabispidine compunds useful in the treatment of cardiac arrhythmias
申请人:Bjore Annika
公开号:US20090326221A1
公开(公告)日:2009-12-31
There is provided compounds of formula I,
wherein R
1
, R
2
, R
3
, R
4
, R
41
to R
46
, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
Oxabispidine compounds useful in the treatment of cardiac arrythmias
申请人:AstraZeneca AB
公开号:EP1559717A2
公开(公告)日:2005-08-03
The present invention relates to a combination comprising component (a) being a compound of formula I,
and component (b), being, at least one other drug useful in the treatment of arrhythmias and / or at least one other drug useful in the treatment of a cardiovascular disorder.
Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
申请人:Roth-Rosendahl Ann-Charlotte
公开号:US20050119259A1
公开(公告)日:2005-06-02
There is provided a combination product comprising: (1) an anti-coagulant; and (1) a compound as defined in claim 1 of WO 01/28992 or (2) a compound of claim 34 of WO 01/28992 or (3) Compound A or B or C or D (or pharmaceutically-acceptable salts thereof) for use in treating arrhythmia or a coagulation controlled complication thereof.
本发明提供了一种组合产品,其包含:(1) 抗凝血剂;和 (1) WO 01/28992 权利要求 1 所定义的化合物或 (2) WO 01/28992 权利要求 34 所定义的化合物或 (3) 化合物 A 或 B 或 C 或 D(或其药学上可接受的盐),用于治疗心律失常或其凝血控制并发症。